Claritas Pharmaceuticals, Inc. Stock
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 5.37M 3.82M 3.35M 3.09M 2.85M 368M 5.45M 36.99M 14.5M 180M 14.34M 14.03M 621M | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29M 4.47M 3.92M 3.62M 3.33M 431M 6.39M 43.33M 16.99M 211M 16.8M 16.43M 727M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| 3 years | 0 |  | 0 |
| 5 years | 0 | | 0.7 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 21/06/2017 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 29/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 18/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/21 | Buy | 118,000 | 0.3332% | |||
| 11/10/21 | Buy | 24,500 | 0.0692% | |||
| 11/10/21 | Buy | 152,500 | 0.4307% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| -0.49% | -3.58% | -0.84% | +2.13% | 49.18B | |
| -3.10% | -3.47% | +370.99% | +567.62% | 39.58B | |
| -0.46% | +3.98% | +5.44% | +60.79% | 34.69B | |
| -1.14% | -1.90% | +26.94% | -9.56% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.54% | -6.91% | - | - | 16.21B | |
| -1.82% | -1.91% | +69.28% | +112.51% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.25% | -0.92% | +15.77% | -32.78% | 13.02B | |
| Average | -1.09% | -0.15% | +63.00% | +93.69% | 24.36B | |
| Weighted average by Cap. | -1.00% | -0.38% | +75.91% | +117.65% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -21.21M -15.09M -13.22M -12.22M -11.24M -1.45B -21.55M -146M -57.3M -712M -56.65M -55.42M -2.45B | 4.21M 2.99M 2.62M 2.43M 2.23M 289M 4.28M 29.01M 11.37M 141M 11.24M 11M 487M |
| Net Debt | 704K 501K 439K 406K 373K 48.29M 715K 4.85M 1.9M 23.63M 1.88M 1.84M 81.4M | 920K 654K 574K 530K 488K 63.1M 935K 6.34M 2.49M 30.87M 2.46M 2.4M 106M |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
